By MATTHEW PERRONE  November 5, 2021 WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for...

Agency holds off decision on expanding use of shot to 12-to-17-year-olds while it looks into risk of rare heart condition The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s Covid-19 vaccine for...